Lacosamide (ADD243037; ADD-243037; ADD 243037; erlosamide; Vimpat) is a marketed anticonvulsant drug used for the adjunctive treatment of partial-onset seizures and diabetic neuropathic pain. It acts by enhancing the slow inactivation of voltage gated sodium channels.